FindTrial
Sign In

The effect of allogeneic peripheral blood stem cell transplantation combined with intra-bone marrow injection on hematopoietic reconstruction and GVHD: quasi-randomised controlled, single center clinical trial

The effect of allogeneic peripheral blood stem cell transplantation combined with intra-bone marrow injection on hematopoietic reconstruction and GVHD: quasi-randomised controlled, single center clinical trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OIQ-16009039
Enrollment
Unknown
Registered
2016-08-17
Start date
2016-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematologic malignancy

Interventions

treatment group:peripheral blood stem cells infusion + Intra-bone marrow injection
control group:peripheral blood stem cells infusion

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged between 10 to 65 years; 2. clear diagnosis hematologic malignancy; 3. prepared for peripheral blood stem cell transplantation.

Exclusion criteria

Exclusion criteria: 1. Serious systemic organ dysfunction; 2. bone marrow puncture point infection; 3. coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
Hematopoietic reconstitution time;the incidence of GVHD;—

Secondary

MeasureTime frame
transfusion requirement;Overall survival;—

Countries

China

Contacts

Public ContactShi-Feng Lou

The Second Affiliated Hospital of Chongqing Medical University

13508331213@163.com+86 13508331213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026